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Introduction / objectives
Enterococci (E.) have become a significant nosocomial
pathogen, and their epidemiology is largely obscured.
Methods
Data were obtained by monitoring of 1946 cases of E.
infections in 1983-2010 including 17 outbreaks with 172
patients. Isolates (1728) were tested for susceptibility to
ampicillin, gentamycin and vancomycin, 31 epidemic
isolates of E.faecium were investigated by MLST (Gdh,
PstS, PurK and AtpA loci).
Results
Before 2000 maximal incidence of E. infections in
Kemerovo Region hospitals was 0,8/1000 patients and
share of E.spp. among all pathogens of HAIs was <2%.
During the past decade the incidence of E. infections
increased 20-fold and mortality rate increased 5-fold.
The E.faecalis/E.faecium ratio was 9:1, but in bacteremia
cases E.faecium was predominant. Hospitalized patients
had 63% isolation rate of E.faecalis, depending on dura-
tion of hospital stay. Primary selection of epidemic E.
spp. clones occurred in ICU, further spreading to other
units. The E.spp epidemic potential was as high as of S.
typhimurium and P.aeruginosa. The level of epidemic
hazard was higher for E.faecium compare to E.faecalis.
The minimal selection time for epidemic clones of E.
spp. was 7 days (maximal circulation-4 months). Specific
allelotype of the purK1 gene was related to hospital out-
breaks. Infections mainly arised from endogenous
sources, mainly after colonization of the gastrointestinal
tract by epidemic E.spp. clones, but infection has also
spread from patient to patient or by hands of healthcare
staff, uniform or indirectly by contaminated surfaces
and equipment. About 40% of E.faecalis isolates and
72% of E.faecium isolates were resistant to ampicillin,
79% and 82% - to gentamycin, respectively. The VRE
share was 31%. Epidemic clones of E. survived on sur-
faces in hospital environment for 37 days.
Conclusion
Our findings can be taken into account for prevention
of HAIs.
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